616 Phase 3 and Ph2/Ph3 industry trials with a readout ahead. Generated by BioIntel from public sources. Not investment advice.
| Readout due | Phase | Sponsor | Dossier | Condition |
|---|---|---|---|---|
| 2026-10-19 | Ph3 | Bristol-Myers Squibb | NCT05620407 | Systemic Lupus Erythematosus |
| 2026-10-19 | Ph3 | Bristol-Myers Squibb | NCT05617677 | Systemic Lupus Erythematosus |
| 2026-10-19 | Ph3 | Incyte Corporation | NCT06516952 | Prurigo Nodularis |
| 2026-10-20 | Ph2/Ph3 | Biogen | NCT05531565 | Subacute Cutaneous Lupus Erythematosus; Chronic Cutaneou |
| 2026-10-26 | Ph3 | Galderma R&D | NCT04204616 | Prurigo Nodularis |
| 2026-10-28 | Ph3 | Akeso | NCT06617416 | NSCLC (Non-small Cell Lung Cancer) |
| 2026-10-28 | Ph2/Ph3 | Hoffmann-La Roche | NCT05115110 | Spinal Muscular Atrophy (SMA) |
| 2026-10-28 | Ph3 | Albireo, an Ipsen Company | NCT05426733 | Biliary Atresia |
| 2026-10-28 | Ph3 | Merck Sharp & Dohme LLC | NCT05239728 | Carcinoma, Renal Cell |
| 2026-10-29 | Ph3 | Novartis Pharmaceuticals | NCT05653349 | Primary Immune Thrombocytopenia (ITP) |
| 2026-10-30 | Ph3 | Natureceuticals Sdn Bhd | NCT07669467 | Fatigue Related to Cancer Treatment; Breast Cancer |
| 2026-10-30 | Ph3 | Pfizer | NCT04657991 | Melanoma |
| 2026-10-30 | Ph3 | Kind Pharmaceuticals LLC | NCT07494409 | Anemia Due to Chronic Kidney Disease |
| 2026-10-30 | Ph3 | CSPC Ouyi Pharmaceutical Co., Ltd. | NCT07026968 | Type 2 Diabetes |
| 2026-10-30 | Ph3 | Cali Pharmaceuticals LLC | NCT07490496 | Postoperative Pain; Bunion |
| 2026-10-30 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT05444257 | Cystic Fibrosis |
| 2026-10-31 | Ph3 | Olema Pharmaceuticals, Inc. | NCT06016738 | Breast Cancer; Advanced Breast Cancer; Metastatic Breast |
| 2026-10-31 | Ph3 | Takeda | NCT04129502 | Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) |
| 2026-10-31 | Ph3 | Sarepta Therapeutics, Inc. | NCT03992430 | Muscular Dystrophy, Duchenne |
| 2026-10-31 | Ph3 | Longboard Pharmaceuticals | NCT06719141 | Developmental and Epileptic Encephalopathy |
| 2026-10-31 | Ph3 | UCB Biopharma SRL | NCT05077904 | Stereotypical Prolonged Seizures |
| 2026-10-31 | Ph3 | Teva Branded Pharmaceutical Products R&D LLC | NCT06052267 | Asthma |
| 2026-10-31 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT04842617 | Hormone Receptor Positive,Human Epidermal Receptor 2 Neg |
| 2026-11-01 | Ph3 | AbbVie | NCT06389136 | Atopic Dermatitis |
| 2026-11-01 | Ph3 | medac GmbH | NCT06239311 | Moderate to Severe Atopic Dermatitis |
| 2026-11-01 | Ph3 | Waterstone Pharmaceutical (Wuhan) Co., LTD. | NCT07251309 | Hyperkalemia |
| 2026-11-01 | Ph3 | Eli Lilly and Company | NCT06662383 | Obesity |
| 2026-11-01 | Ph3 | Sandoz | NCT06847724 | Relapsing Multiple Sclerosis |
| 2026-11-01 | Ph3 | DBV Technologies | NCT07003919 | Allergy; Peanut Allergy |
| 2026-11-01 | Ph3 | NewAmsterdam Pharma | NCT05202509 | Atherosclerotic Cardiovascular Disease |
| 2026-11-01 | Ph3 | Sichuan Kelun-Biotech Biopharmaceutical Co., | NCT06448312 | Non-Small Cell Lung Cancer |
| 2026-11-01 | Ph3 | Eli Lilly and Company | NCT06914895 | Type 1 Diabetes; Obesity; Overweight |
| 2026-11-01 | Ph3 | Nanjing Chia-tai Tianqing Pharmaceutical | NCT07177859 | Paroxysmal Nocturnal Hemoglobinuria |
| 2026-11-01 | Ph3 | Epygenix | NCT05066217 | Lennox Gastaut Syndrome |
| 2026-11-01 | Ph2/Ph3 | Nuance Hearing | NCT07282028 | Hearing Loss Mixed |
| 2026-11-01 | Ph3 | Eli Lilly and Company | NCT06962280 | Type 1 Diabetes; Obesity; Overweight |
| 2026-11-02 | Ph3 | Bristol-Myers Squibb | NCT06951711 | Bipolar Disorder Type I With Mania or Mania With Mixed F |
| 2026-11-03 | Ph3 | Novartis Pharmaceuticals | NCT05677451 | Chronic Spontaneous Urticaria |
| 2026-11-04 | Ph3 | CMG Pharmaceutical Co. Ltd | NCT06772168 | Dyslipidemia; Type 2 Diabetes |
| 2026-11-09 | Ph3 | LEAF4Life, Inc. | NCT06640777 | Acute Respiratory Distress Syndrome |
| 2026-11-11 | Ph3 | AstraZeneca | NCT04784715 | Breast Cancer; HER2-positive; Metastatic |
| 2026-11-12 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06671548 | Heavy Menstrual Bleeding; Uterine Fibroids |
| 2026-11-13 | Ph3 | Hoffmann-La Roche | NCT05646862 | Breast Cancer |
| 2026-11-14 | Ph3 | BrightGene Bio-Medical Technology Co., Ltd. | NCT06716203 | Type 2 Diabetes Mellitus (T2DM) |
| 2026-11-18 | Ph2/Ph3 | Han Xu, M.D., Ph.D., FAPCR, Medical Director | NCT01064466 | Small Cell Lung Cancer |
| 2026-11-21 | Ph3 | Changchun GeneScience Pharmaceutical Co., Lt | NCT07124221 | Hyperprolactinemia |
| 2026-11-26 | Ph3 | Tesaro, Inc. | NCT03981796 | Neoplasms |
| 2026-11-28 | Ph3 | Sanofi | NCT07103148 | Yellow Fever Immunization |
| 2026-11-28 | Ph3 | Haisco Pharmaceutical Group Co., Ltd. | NCT06660992 | Non-cystic Fibrosis Bronchiectasis |
| 2026-11-30 | Ph2/Ph3 | Cytopeutics Sdn. Bhd. | NCT06129175 | Acute Ischemic Stroke |
| 2026-11-30 | Ph3 | InventisBio Co., Ltd | NCT06954961 | Breast Cancer |
| 2026-11-30 | Ph3 | Sanofi | NCT07216079 | Immune Thrombocytopenia |
| 2026-11-30 | Ph3 | Zhejiang Wenda Pharma Technology LTD. | NCT07672561 | Moderate to Severe Plaque Psoriasis |
| 2026-11-30 | Ph3 | Hoffmann-La Roche | NCT03148418 | Cancer |
| 2026-11-30 | Ph2/Ph3 | CAS Lamvac (Guangzhou) Biomedical Technology | NCT05924776 | Advanced Ovarian Cancer |
| 2026-11-30 | Ph3 | Saol Therapeutics Inc | NCT07226258 | Osteoarthritis Knee Pain |
| 2026-11-30 | Ph3 | Gritgen Therapeutics Co., Ltd. | NCT06833983 | Hemophilia A |
| 2026-11-30 | Ph3 | Tolmar Inc. | NCT04906395 | Breast Cancer |
| 2026-12-01 | Ph3 | Kedrion S.p.A. | NCT07059000 | Chronic Primary Immune Thrombocytopenia (ITP) |
| 2026-12-01 | Ph3 | Kind Pharmaceuticals LLC | NCT07487727 | Anemia Due to Chronic Kidney Disease |
| 2026-12-01 | Ph3 | Inmunotek S.L. | NCT04435990 | Rhinitis, Allergic; Rhinoconjunctivitis; Asthma, Allergi |
| 2026-12-01 | Ph3 | MediWound Ltd | NCT06568627 | Venous Leg Ulcer (VLU) |
| 2026-12-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Co., | NCT04344158 | Advanced Hepatocellular Carcinoma (HCC) |
| 2026-12-01 | Ph3 | Suven Life Sciences Limited | NCT05397639 | Agitation; Alzheimer's Type Dementia |
| 2026-12-01 | Ph3 | Chengdu Kangnuoxing Biopharma,Inc. | NCT07678931 | Seasonal Allergic Rhinitis (SAR) |
| 2026-12-01 | Ph3 | TR Therapeutics | NCT06707103 | Venous Leg Ulcer; Venous Ulcer; Venous Stasis Ulcer; Ven |
| 2026-12-01 | Ph3 | Nanjing Chia-tai Tianqing Pharmaceutical | NCT06512363 | Chronic Insomnia |
| 2026-12-01 | Ph3 | Guangdong Hengrui Pharmaceutical Co., Ltd | NCT07688772 | Seasonal Allergic Rhinitis |
| 2026-12-01 | Ph3 | Guangdong Raynovent Biotech Co., Ltd | NCT07139548 | T2DM |
| 2026-12-01 | Ph3 | Tasly Pharmaceutical Group Co., Ltd | NCT06000956 | Ankylosing Spondylitis |
| 2026-12-01 | Ph3 | Celltrion | NCT07093476 | T2DM; Diabete Type 2; DM |
| 2026-12-01 | Ph3 | Vir Biotechnology, Inc. | NCT07128550 | Viral Hepatitis |
| 2026-12-01 | Ph3 | Minghui Pharmaceutical (Hangzhou) Ltd | NCT06989918 | Thyroid Associated Ophthalmopathies |
| 2026-12-01 | Ph3 | Vanda Pharmaceuticals | NCT07446439 | Nausea and Vomiting; Obesity |
| 2026-12-01 | Ph2/Ph3 | iCoat Medical AB | NCT06582485 | Ischemia-reperfusion Injury; Kidney Transplant; Complica |
| 2026-12-01 | Ph3 | RayzeBio, Inc. | NCT05477576 | GEP-NET; Gastroenteropancreatic Neuroendocrine Tumor; Ga |
| 2026-12-01 | Ph3 | Krystal Biotech, Inc. | NCT07016750 | Dystrophic Epidermolysis Bullosa; DEB - Dystrophic Epide |
| 2026-12-01 | Ph3 | Sanofi Pasteur, a Sanofi Company | NCT06838000 | Pneumococcal Infections |
| 2026-12-01 | Ph3 | AbbVie | NCT06468228 | Hidradenitis Suppurativa |
| 2026-12-01 | Ph3 | Ionis Pharmaceuticals, Inc. | NCT05392114 | Hereditary Angioedema |
| 2026-12-01 | Ph3 | Fujian Akeylink Biotechnology Co., Ltd. | NCT07090759 | Chronic Hepatitis b |
| 2026-12-01 | Ph3 | Sichuan Baili Pharmaceutical Co., Ltd. | NCT06500026 | Small Cell Lung Cancer |
| 2026-12-01 | Ph3 | Pacira Pharmaceuticals, Inc | NCT06269705 | Glenohumeral Osteoarthritis |
| 2026-12-01 | Ph3 | Vanda Pharmaceuticals | NCT07221578 | Social Anxiety Disorder (SAD) |
| 2026-12-01 | Ph3 | Otsuka Pharmaceutical Co., Ltd. | NCT07173478 | Atopic Dermatitis (AD) |
| 2026-12-01 | Ph3 | Aldeyra Therapeutics, Inc. | NCT07402876 | Primary Vitreoretinal Lymphoma |
| 2026-12-01 | Ph3 | Virchow Group | NCT07017036 | Primary Immunodeficiency Diseases (PID) |
| 2026-12-01 | Ph3 | Octapharma | NCT06361537 | Acute Hereditary Angio Edema |
| 2026-12-01 | Ph3 | Janssen Research & Development, LLC | NCT03767244 | Prostatic Neoplasms |
| 2026-12-01 | Ph2/Ph3 | Shanghai Pharmaceuticals Holding Co., Ltd | NCT05860465 | Locally Advanced or Metastatic Breast Cancer |
| 2026-12-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Co., | NCT05987358 | Biliary Carcinoma |
| 2026-12-01 | Ph2/Ph3 | Oculis | NCT07548632 | Dry Eye Disease (DED) |
| 2026-12-01 | Ph3 | Octapharma | NCT04918173 | Congenital Antithrombin Deficiency |
| 2026-12-01 | Ph3 | GC Cell Corporation | NCT04969731 | Pancreatic Ductal Adenocarcinoma |
| 2026-12-01 | Ph3 | Allist Pharmaceuticals, Inc. | NCT04853342 | Non-small Cell Lung Carcinoma |
| 2026-12-01 | Ph3 | Astria Therapeutics, Inc. | NCT06842823 | Hereditary Angioedema (HAE) |
| 2026-12-01 | Ph3 | JYAMS PET Research & Development Limited | NCT07422857 | Subjects With Mild Cognitive Impairment (MCI) of AD, Alz |
| 2026-12-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Co., | NCT05780567 | Breast Cancer |
| 2026-12-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06754644 | NSCLC |
| 2026-12-01 | Ph3 | Atea Pharmaceuticals, Inc. | NCT07037277 | HEPATITIS C VIRUS CHRONIC INFECTION; Hepatitis C, Chroni |
| 2026-12-01 | Ph3 | Axsome Therapeutics, Inc. | NCT06568367 | Excessive Sleepiness; Shift-work Disorder |
| 2026-12-01 | Ph2/Ph3 | Napo Pharmaceuticals, Inc. | NCT06721871 | Microvillus Inclusion Disease; Congenital Disorders; Rar |
| 2026-12-01 | Ph3 | Kedrion S.p.A. | NCT04944979 | Primary Immunodeficiency Disease |
| 2026-12-01 | Ph3 | Gossamer Bio USA, Inc. | NCT06274801 | Pulmonary Arterial Hypertension |
| 2026-12-01 | Ph2/Ph3 | DiaMedica Therapeutics Inc | NCT05065216 | Acute Stroke; Ischemic Stroke; Stroke |
| 2026-12-01 | Ph3 | Cook MyoSite | NCT05776277 | Fecal Incontinence |
| 2026-12-01 | Ph2/Ph3 | Karyopharm Therapeutics Inc | NCT04442022 | Relapsed/Refractory Diffuse Large B-cell Lymphoma |
| 2026-12-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT07089186 | Hospital-acquired Bacterial Pneumonia (HABP); Ventilator |
| 2026-12-01 | Ph3 | Sound Pharmaceuticals, Incorporated | NCT06859788 | Meniere's Disease; Ménière's Disease |
| 2026-12-01 | Ph3 | Akeso | NCT06767527 | Triple-Negative Breast Cancer (TNBC) |
| 2026-12-01 | Ph3 | Axsome Therapeutics, Inc. | NCT06413433 | Binge-Eating Disorder |
| 2026-12-02 | Ph3 | Pfizer | NCT06629779 | Metastatic Castration-Resistant Prostate Cancer |
| 2026-12-04 | Ph3 | Pfizer | NCT07500506 | Lyme Disease |
| 2026-12-07 | Ph3 | Alexion Pharmaceuticals, Inc. | NCT06724809 | NMOSD; Neuromyelitis Optica Spectrum Disorders |
| 2026-12-08 | Ph3 | Janssen Research & Development, LLC | NCT05757869 | Atrial Fibrillation |
| 2026-12-10 | Ph3 | Boehringer Ingelheim | NCT06151574 | Lung Cancer, Non-squamous, Non-small Cell |
| 2026-12-13 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT04957550 | Psoriatic Arthritis |
| 2026-12-15 | Ph3 | Ipsen | NCT07435428 | Moderate to Severe Glabellar Lines |
| 2026-12-15 | Ph3 | Ipsen | NCT07427797 | Moderate to Severe Glabellar Lines |
| 2026-12-15 | Ph3 | Alexion Pharmaceuticals, Inc. | NCT06607627 | Generalized Myasthenia Gravis; gMG |
| 2026-12-15 | Ph3 | Gedeon Richter Plc. | NCT03817502 | Schizophrenia |
| 2026-12-16 | Ph3 | Shanghai JMT-Bio Inc. | NCT06747338 | Early or Locally Advanced HER2-positive Breast Cancer |
| 2026-12-18 | Ph2/Ph3 | Han Xu, M.D., Ph.D., FAPCR, Medical Director | NCT07145333 | SCLC |
| 2026-12-18 | Ph3 | Ausper Biopharma Co., Ltd. | NCT07246889 | Chronic Hepatitis B |
| 2026-12-18 | Ph2/Ph3 | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investig | NCT06062810 | Breast Cancer |
| 2026-12-21 | Ph3 | UCB Biopharma SRL | NCT06921850 | Hidradenitis Suppurativa |
| 2026-12-22 | Ph3 | Adverum Biotechnologies, Inc. | NCT06856577 | Neovascular Age-Related Macular Degeneration (nAMD); Wet |
| 2026-12-22 | Ph3 | Taisho Pharmaceutical Co., Ltd. | NCT07285291 | Hyperphosphatemia Patients on Hemodialysis |
| 2026-12-23 | Ph3 | AstraZeneca | NCT05692180 | Asthma |
| 2026-12-23 | Ph3 | OncoZenge AB | NCT07672236 | Head & Neck Cancer; Oral Mucositis |
| 2026-12-24 | Ph3 | Shanghai Kechow Pharma, Inc. | NCT06008119 | Colorectal Cancer Metastatic |
| 2026-12-25 | Ph3 | GlaxoSmithKline | NCT06740630 | Chickenpox |
| 2026-12-25 | Ph3 | Jiangsu Healthy Life Innovation Medical Tech | NCT05653453 | Locally Advanced Pancreatic Cancer |
| 2026-12-28 | Ph3 | Pfizer | NCT06551324 | Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
| 2026-12-28 | Ph3 | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | NCT06925594 | Crohn's Disease |
| 2026-12-30 | Ph3 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | NCT06751485 | Ovarian Cancer; Primary Peritoneal; Fallopian Tube Cance |
| 2026-12-30 | Ph3 | AskGene Pharma, Inc. | NCT06206733 | Gastroesophageal Junction Adenocarcinoma; Gastric Adenoc |
| 2026-12-30 | Ph2/Ph3 | Beijing Continent Pharmaceutical Co, Ltd. | NCT07388680 | Radiation-induced Lung Injury; Immune-related Pneumonia |
| 2026-12-30 | Ph3 | Innovent Biologics (Suzhou) Co. Ltd. | NCT06238843 | Unresectable or Metastatic Gastric or Gastroesophageal J |
| 2026-12-30 | Ph3 | Janssen Research & Development, LLC | NCT04658862 | Urinary Bladder Neoplasms |
| 2026-12-30 | Ph2/Ph3 | Quoin Pharmaceuticals | NCT06953466 | Netherton Syndrome |
| 2026-12-30 | Ph3 | Janssen Research & Development, LLC | NCT06559306 | Depressive Disorder, Major |
| 2026-12-30 | Ph3 | Getz Pharma | NCT07174297 | Postprandial Distress Syndrome |
| 2026-12-30 | Ph3 | Beijing Konruns Pharmaceutical Co., Ltd. | NCT06194734 | Esophageal Squamous Cell Carcinoma |
| 2026-12-30 | Ph2/Ph3 | Shanghai Jiaolian Drug Research and Developm | NCT06447597 | Generalized Myasthenia Gravis |
| 2026-12-30 | Ph3 | Xynomic Pharmaceuticals, Inc. | NCT03592472 | Renal Cell Carcinoma |
| 2026-12-30 | Ph3 | Novartis Pharmaceuticals | NCT02962414 | Tuberous Sclerosis Complex |
| 2026-12-30 | Ph3 | Sinovac Biotech Co., Ltd | NCT07055295 | Rabies |
| 2026-12-30 | Ph3 | Cartesian Therapeutics | NCT06799247 | Myasthaenia Gravis |
| 2026-12-30 | Ph2/Ph3 | Wuhan Createrna Science and Technology Co., | NCT06933914 | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| 2026-12-30 | Ph3 | Jiangsu vcare pharmaceutical technology co., | NCT06577519 | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Co |
| 2026-12-31 | Ph3 | Cloudbreak Therapeutics, LLC | NCT05456425 | Pterygium |
| 2026-12-31 | Ph3 | HK inno.N Corporation | NCT07192263 | Obesity &Amp; Overweight |
| 2026-12-31 | Ph3 | AstraZeneca | NCT05303532 | Cancer |
| 2026-12-31 | Ph3 | RemeGen Co., Ltd. | NCT07249632 | Myasthenia Gravis, Ocular |
| 2026-12-31 | Ph3 | Clarity Pharmaceuticals Ltd | NCT06970847 | Prostate Cancer; Prostate Cancer Patients With Detectabl |
| 2026-12-31 | Ph2/Ph3 | Olatec Therapeutics, Inc. | NCT05658575 | Acute Gout Flare; Gout Attack; Gout Flare; Gouty Arthrit |
| 2026-12-31 | Ph3 | Amicus Therapeutics | NCT04020055 | Fabry Disease |
| 2026-12-31 | Ph3 | PT Bio Farma | NCT07824310 | Human Papillomavirus (HPV) Infection |
| 2026-12-31 | Ph3 | Ascentage Pharma Group Inc. | NCT06104566 | CLL/SLL |
| 2026-12-31 | Ph3 | Changchun GeneScience Pharmaceutical Co., Lt | NCT06961201 | Extensive-stage Small Cell Lung Cancer (ES-SCLC); The Pr |
| 2026-12-31 | Ph3 | Eisai Inc. | NCT03887455 | Early Alzheimer's Disease |
| 2026-12-31 | Ph3 | AUG Therapeutics | NCT05754450 | Leukocyte Adhesion Deficiency |
| 2026-12-31 | Ph3 | Pfizer | NCT05059522 | Advanced Malignancies; NSCLC; Ovarian Cancer; Urothelial |
| 2026-12-31 | Ph2/Ph3 | Shanghai Jiaolian Drug Research and Developm | NCT06454357 | Pemphigus |
| 2026-12-31 | Ph3 | Tasly Pharmaceutical Group Co., Ltd | NCT06696261 | Postprandial Distress Syndrome |
| 2026-12-31 | Ph3 | Materia Medica Holding | NCT06284265 | Cystitis Chronic; Cystitis Bacterial; Recurrence of Chro |
| 2026-12-31 | Ph3 | RemeGen Co., Ltd. | NCT05302284 | Urothelial Carcinoma; HER2-expressing |
| 2026-12-31 | Ph2/Ph3 | AMO Pharma Limited | NCT05004129 | Congenital Myotonic Dystrophy |
| 2026-12-31 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT05424835 | HER2-Positive, Unresectable and/or Metastatic Breast Can |
| 2026-12-31 | Ph3 | Kartos Therapeutics, Inc. | NCT06479135 | Myelofibrosis; Post-PV MF; Post-ET Myelofibrosis; Primar |
| 2026-12-31 | Ph3 | Longboard Pharmaceuticals | NCT06660394 | Dravet Syndrome |
| 2026-12-31 | Ph3 | Laboratorios Silanes S.A. de C.V. | NCT06863701 | Gout Arthritis; Gout Attack |
| 2026-12-31 | Ph3 | Serum Institute of India Pvt. Ltd. | NCT06281119 | Human Papillomavirus Infection |
| 2026-12-31 | Ph3 | Sichuan Kelun-Biotech Biopharmaceutical Co., | NCT06081959 | Metastatic Breast Cancer |
| 2026-12-31 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT04691804 | Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| 2026-12-31 | Ph3 | Innovent Biologics (Suzhou) Co. Ltd. | NCT06884293 | Overweight; Metabolic Dysfunction-associated Fatty Liver |
| 2026-12-31 | Ph3 | Boehringer Ingelheim | NCT06531824 | Kidney Disease, Chronic |
| 2026-12-31 | Ph2/Ph3 | Guangzhou JOYO Pharma Co., Ltd | NCT06125327 | Idiopathic Pulmonary Fibrosis |
| 2026-12-31 | Ph3 | TRB Chemedica | NCT04318041 | Knee Osteoarthritis |
| 2026-12-31 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT07162883 | Carcinoma, Non-Small-Cell Lung |
| 2026-12-31 | Ph2/Ph3 | Insmed Incorporated | NCT05649748 | Pulmonary Arterial Hypertension |
| 2026-12-31 | Ph3 | Corza Medical GmbH | NCT06664775 | Hemorrhage |
| 2027-01-01 | Ph2/Ph3 | QED Therapeutics, a BridgeBio company | NCT06873035 | Hypochondroplasia |
| 2027-01-01 | Ph3 | Telix Pharmaceuticals (Innovations) Pty Limi | NCT07052214 | PCA; Prostate Cancer; Prostatic Neoplasm; PSMA PET; Diag |
| 2027-01-01 | Ph3 | AbbVie | NCT06701331 | Atopic Dermatitis |
| 2027-01-01 | Ph3 | Ultragenyx Pharmaceutical Inc | NCT06636071 | Osteogenesis Imperfecta |
| 2027-01-01 | Ph3 | Lexicon Pharmaceuticals | NCT06481891 | Obstructive Cardiomyopathy, Hypertrophic; Non-obstructiv |
| 2027-01-01 | Ph3 | Vantive Health LLC | NCT05399537 | Regional Citrate Anticoagulation (RCA); Continuous Renal |
| 2027-01-01 | Ph3 | Praxis Precision Medicines | NCT07505004 | Focal Epilepsy |
| 2027-01-01 | Ph3 | Adneuris Therapeutics, Inc. | NCT07845071 | Pain |
| 2027-01-01 | Ph3 | Reistone Biopharma Company Limited | NCT07543224 | Plaque Psoriasis Subjects |
| 2027-01-01 | Ph3 | Colgate Palmolive | NCT07842991 | Plaque; Dental Plaque; Gingivitis |
| 2027-01-01 | Ph3 | Xenon Pharmaceuticals Inc. | NCT06922110 | Major Depressive Disorder |
| 2027-01-01 | Ph3 | Alcon Research | NCT07578363 | Ocular Hyperemia |
| 2027-01-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT07062978 | Postmenopausal Women With Osteoporosis at High Risk of F |
| 2027-01-01 | Ph3 | A. Menarini International Licensing S.A. | NCT07614958 | Mixed Dyslipidemia; Hypercholesterolaemia |
| 2027-01-01 | Ph3 | Sun Pharmaceutical Industries, Inc. | NCT07144852 | Actinic Keratosis |
| 2027-01-01 | Ph3 | Akeso | NCT06601335 | Head and Neck Squamous Cell Carcinoma |
| 2027-01-01 | Ph2/Ph3 | Hyundai Bioscience Co., Ltd. | NCT07576868 | Dengue |
| 2027-01-04 | Ph3 | AstraZeneca | NCT07000136 | Heterozygous Familial Hypercholesterolaemia |
| 2027-01-05 | Ph3 | Shanghai Mabgeek Biotech.Co.Ltd | NCT07540442 | Dermatitis, Atopic |
| 2027-01-07 | Ph3 | Sanofi | NCT07247188 | Sickle Cell Disease |
| 2027-01-08 | Ph3 | Ocular Therapeutix, Inc. | NCT06495918 | Neovascular Age-related Macular Degeneration |
| 2027-01-10 | Ph3 | Celgene | NCT05519085 | Relapsed or Refractory Multiple Myeloma |
| 2027-01-11 | Ph3 | AstraZeneca | NCT06417814 | Metastatic Non-small Cell Lung Cancer |
| 2027-01-11 | Ph3 | FutureGen Biopharmaceutical (Beijing) Co., L | NCT06177041 | Locally Advanced Unresectable or Metastatic Gastric Canc |
| 2027-01-12 | Ph3 | Merck Sharp & Dohme LLC | NCT05609968 | Carcinoma, Non-Small-Cell Lung |
| 2027-01-13 | Ph3 | AstraZeneca | NCT06706817 | Chronic Rhinosinusitis With Nasal Polyps |
| 2027-01-15 | Ph3 | Merck Sharp & Dohme LLC | NCT04199689 | Papillomavirus Infections |
| 2027-01-15 | Ph3 | Bioverativ, a Sanofi company | NCT04644575 | Hemophilia A |
| 2027-01-15 | Ph2/Ph3 | IDEAYA Biosciences | NCT05987332 | Metastatic Uveal Melanoma |
| 2027-01-18 | Ph3 | Pfizer | NCT05035212 | Lower Respiratory Tract Illness |
| 2027-01-20 | Ph2/Ph3 | Turn Therapeutics | NCT07355075 | Eczema Atopic Dermatitis; Eczema; Atopic Dermatitis |
| 2027-01-21 | Ph3 | TG Therapeutics, Inc. | NCT05877963 | Relapsing Multiple Sclerosis |
| 2027-01-21 | Ph3 | Amgen | NCT06858878 | Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight |
| 2027-01-21 | Ph3 | Amgen | NCT06858839 | Obesity |
| 2027-01-26 | Ph3 | GlaxoSmithKline | NCT05757102 | Asthma |
| 2027-01-28 | Ph3 | Novartis Pharmaceuticals | NCT05038735 | Breast Cancer |
| 2027-01-29 | Ph3 | Novartis Pharmaceuticals | NCT04817618 | C3G |
| 2027-01-29 | Ph3 | Novo Nordisk A/S | NCT06118281 | Cardiovascular Risk; Acute Myocardial Infarction (AMI) |
| 2027-01-30 | Ph3 | Shanghai Runshi Pharmaceutical Technology Co | NCT06656091 | Advanced Oesophageal Squamous Cell Carcinoma |
| 2027-01-31 | Ph3 | Ono Pharmaceutical Co., Ltd. | NCT06579573 | Epilepsy, Generalized |
| 2027-01-31 | Ph3 | iRenix Medical, Inc. | NCT05750589 | Retinal Disease |
| 2027-01-31 | Ph3 | Merck Sharp & Dohme LLC | NCT04241185 | Urinary Bladder Neoplasms |
| 2027-01-31 | Ph3 | Actelion | NCT05179876 | Hypertension, Pulmonary |
| 2027-02-01 | Ph3 | PT Bio Farma | NCT07854847 | Vaccination Adverse Event; Immunogenicity, Vaccine |
| 2027-02-01 | Ph3 | Eurofarma Laboratorios S.A. | NCT06905210 | Acne Vulgaris; Acne Vulgaris on the Face |
| 2027-02-01 | Ph3 | Otsuka Pharmaceutical Co., Ltd. | NCT07184645 | Atopic Dermatitis (AD) |
| 2027-02-01 | Ph3 | EMS | NCT06268054 | Primary Dysmenorrhea |
| 2027-02-01 | Ph3 | Eli Lilly and Company | NCT06672549 | Obesity; Overweight |
| 2027-02-01 | Ph3 | Gilead Sciences | NCT05382286 | Triple Negative Breast Cancer; PD-L1 Positive |
| 2027-02-01 | Ph3 | SK Life Science, Inc. | NCT05219617 | Seizures; Lennox Gastaut Syndrome |
| 2027-02-01 | Ph3 | Sunshine Guojian Pharmaceutical (Shanghai) C | NCT06323213 | Asthma |
| 2027-02-01 | Ph3 | Kodiak Sciences Inc | NCT06996080 | Macular Edema Secondary to Inflammation |
| 2027-02-01 | Ph3 | Trust Bio-sonics, Inc. | NCT06815627 | Cardiac Diseases |
| 2027-02-02 | Ph2/Ph3 | Noema Pharma AG | NCT05217628 | Trigeminal Neuralgia |
| 2027-02-04 | Ph3 | Hoffmann-La Roche | NCT04657289 | Neovascular Age-related Macular Degeneration (nAMD) |
| 2027-02-10 | Ph3 | Janssen Research & Development, LLC | NCT06260163 | Colitis, Ulcerative |
| 2027-02-13 | Ph3 | Epizyme, Inc. | NCT04224493 | Relapsed/Refractory Follicular Lymphoma; Follicular Lymp |
| 2027-02-15 | Ph3 | Acerta Pharma BV | NCT02972840 | Lymphoma, Mantle Cell |
| 2027-02-15 | Ph3 | CanSino Biologics Inc. | NCT07017777 | Pneumococcal Infections; Streptococcal Infections; Bacte |
| 2027-02-18 | Ph3 | AstraZeneca | NCT06087835 | Chronic Kidney Disease With High Proteinuria |
| 2027-02-22 | Ph3 | AstraZeneca | NCT05629234 | Cancer |
| 2027-02-22 | Ph3 | Novartis Pharmaceuticals | NCT06868212 | Chronic Spontaneous Urticaria (CSU) |
| 2027-02-25 | Ph3 | GlaxoSmithKline | NCT07645248 | Asthma |
| 2027-02-26 | Ph3 | Ardelyx | NCT07382167 | Chronic Idiopathic Constipation (CIC) |
| 2027-02-28 | Ph3 | Institut Pasteur | NCT05821478 | Hidradenitis Suppurativa |
| 2027-03-01 | Ph3 | Sinovac Life Sciences Co., Ltd. | NCT07832500 | Pneumococcal Infectious Diseases |
| 2027-03-01 | Ph3 | Stoke Therapeutics, Inc | NCT06872125 | Dravet Syndrome |
| 2027-03-01 | Ph3 | Novo Nordisk A/S | NCT07011667 | Obesity |
| 2027-03-01 | Ph3 | AbbVie | NCT05843643 | Systemic Lupus Erythematosus |
| 2027-03-01 | Ph2/Ph3 | argenx | NCT04833894 | Generalized Myasthenia Gravis |
| 2027-03-01 | Ph3 | Amicus Therapeutics | NCT03911505 | Pompe Disease (Late-onset) |
| 2027-03-01 | Ph3 | Smilebiotek Zhuhai Limited | NCT07189169 | Intermediate Age-Related Macular Degeneration |
| 2027-03-01 | Ph3 | AbbVie | NCT04777357 | Depression; Bipolar I Disorder |
| 2027-03-01 | Ph3 | Ionis Pharmaceuticals, Inc. | NCT05681351 | Severe Hypertriglyceridemia |
| 2027-03-01 | Ph3 | GlaxoSmithKline | NCT07671001 | Asthma |
| 2027-03-01 | Ph3 | Merz Therapeutics GmbH | NCT07018713 | Chronic Migraine |
| 2027-03-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Co., | NCT06900920 | Primary Immune Thrombocytopenia |
| 2027-03-01 | Ph3 | Merz Therapeutics GmbH | NCT07018700 | Episodic Migraine |
| 2027-03-01 | Ph3 | Megalabs | NCT06352138 | Anemia of Chronic Kidney Disease |
| 2027-03-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Co., | NCT07147946 | Chronic Obstructive Pulmonary Disease |
| 2027-03-01 | Ph3 | Ache Laboratorios Farmaceuticos S.A. | NCT07880392 | Acute Pain |
| 2027-03-01 | Ph3 | AbbVie | NCT06063967 | Crohn's Disease |
| 2027-03-01 | Ph3 | Swedish Orphan Biovitrum | NCT06716814 | Haemophilia A (Moderate or Severe) |
| 2027-03-01 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT07241416 | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| 2027-03-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06880276 | Atopic Dermatitis |
| 2027-03-01 | Ph3 | Shanghai Chia Tai Tianqing Pharmaceutical Te | NCT07107256 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) |
| 2027-03-01 | Ph2/Ph3 | EyeBiotech Ltd. | NCT06957080 | Diabetic Macular Edema (DME) |
| 2027-03-01 | Ph3 | Vaxcyte, Inc. | NCT07365826 | Pneumococcal Vaccines |
| 2027-03-01 | Ph3 | Aragon Pharmaceuticals, Inc. | NCT02531516 | Prostatic Neoplasms |
| 2027-03-07 | Ph3 | Hansoh BioMedical R&D Company | NCT06855069 | Ovarian Cancer |
| 2027-03-09 | Ph3 | UCB Biopharma SRL | NCT06506916 | Moderate to Severe Plaque Psoriasis; Psoriatic Arthritis |
| 2027-03-11 | Ph3 | Bristol-Myers Squibb | NCT03873402 | Renal Cell Carcinoma |
| 2027-03-13 | Ph3 | Rhythm Pharmaceuticals, Inc. | NCT06760546 | Hypothalamic Obesity; Multiple Pituitary Hormone Deficie |
| 2027-03-14 | Ph3 | Zai Lab (Shanghai) Co., Ltd. | NCT07211776 | Thyroid Eye Disease (TED) |
| 2027-03-16 | Ph3 | Takeda | NCT04683003 | Thrombotic Thrombocytopenic Purpura (TTP) |
| 2027-03-17 | Ph3 | Pfizer | NCT04624230 | Ulcerative Colitis |
| 2027-03-25 | Ph3 | Janssen-Cilag Ltd. | NCT05347095 | Fistulizing Crohns Disease; Perianal Crohns Disease |
| 2027-03-25 | Ph3 | Sanofi | NCT05662319 | Hemophilia |
| 2027-03-28 | Ph3 | Anhui Zhifei Longcom Biologic Pharmacy Co., | NCT06524947 | Acute Gastroenteropathy Due to Norovirus |
| 2027-03-30 | Ph3 | Shin Poong Pharmaceutical Co. Ltd. | NCT06660719 | Ischemic Stroke |
| 2027-03-30 | Ph3 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | NCT07156500 | Type 2 Diabetes |
| 2027-03-31 | Ph2/Ph3 | TuHURA Biosciences, Inc. | NCT06947928 | Advanced Or Metastatic Merkel Cell Carcinoma |
| 2027-03-31 | Ph3 | Pierre Fabre Medicament | NCT05270044 | Melanoma |
| 2027-03-31 | Ph3 | Hoffmann-La Roche | NCT05199688 | Neuromyelitis Optica Spectrum Disorder; NMOSD |
| 2027-03-31 | Ph3 | Pfizer | NCT06163326 | Vitiligo |
| 2027-03-31 | Ph3 | Hangzhou Sumgen Biotech Co., Ltd. | NCT06508983 | Relapsed/Refractory Multiple Myeloma |
| 2027-03-31 | Ph3 | Sinovac Life Sciences Co., Ltd. | NCT07633119 | Tetanus |
| 2027-03-31 | Ph3 | Newron Pharmaceuticals SPA | NCT07184619 | Treatment-resistant Schizophrenia |
| 2027-03-31 | Ph3 | Viatris Innovation GmbH | NCT05648500 | Lupus Erythematosus, Systemic |
| 2027-03-31 | Ph3 | Hansoh BioMedical R&D Company | NCT06844799 | Moderate-to-severe Plaque Psoriasis |
| 2027-03-31 | Ph3 | Natureceuticals Sdn Bhd | NCT07669519 | Fatigue; Colon Cancer |
| 2027-03-31 | Ph3 | Ascentage Pharma Group Inc. | NCT06640361 | GIST |
| 2027-03-31 | Ph3 | Regenerative Ocular Immunobiologics LLC | NCT07776210 | oGVHD; Ocular Graft Versus Host Disease |
| 2027-03-31 | Ph3 | Hoffmann-La Roche | NCT04873362 | Breast Cancer |
| 2027-04-01 | Ph3 | mAbxience Research S.L. | NCT07221734 | Advanced (Unresectable or Metastatic) Melanoma |
| 2027-04-01 | Ph2/Ph3 | Coya Therapeutics | NCT07161999 | Amyotrophic Lateral Sclerosis (ALS) |
| 2027-04-01 | Ph3 | RHEACELL GmbH & Co. KG | NCT06489028 | Venous Leg Ulcer |
| 2027-04-01 | Ph2/Ph3 | Kaneka Americas Holding Inc. | NCT07527572 | Vaginosis, Bacterial; Bacterial Vaginosis; Bacterial Vag |
| 2027-04-01 | Ph3 | Epygenix | NCT04462770 | Dravet Syndrome |
| 2027-04-01 | Ph3 | Shenzhen Sciencare Medical Industries Co., L | NCT07433413 | Alcohol Use Disorder (AUD) |
| 2027-04-01 | Ph3 | Beijing Kanghong Biological Medicine Co., Lt | NCT07720635 | Thyroid Eye Disease |
| 2027-04-01 | Ph2/Ph3 | MediciNova | NCT04057898 | Amyotrophic Lateral Sclerosis |
| 2027-04-01 | Ph3 | Biocad | NCT06700096 | Hemophilia B |
| 2027-04-01 | Ph3 | vTv Therapeutics | NCT06334133 | Diabetes Mellitus, Type 1 |
| 2027-04-01 | Ph3 | Xenon Pharmaceuticals Inc. | NCT05667142 | Primary Generalized Tonic-Clonic Seizures |
| 2027-04-01 | Ph3 | Kodiak Sciences Inc | NCT06990399 | Macular Edema Secondary to Inflammation |
| 2027-04-01 | Ph2/Ph3 | Taiho Oncology, Inc. | NCT06506955 | Advanced/Metastatic Cancer |
| 2027-04-01 | Ph3 | Harmony Biosciences Management, Inc. | NCT06366464 | Prader-Willi Syndrome |
| 2027-04-06 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT05331183 | Cystic Fibrosis |
| 2027-04-06 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT07231419 | Diabetic Peripheral Neuropathic Pain |
| 2027-04-06 | Ph3 | CSL Behring | NCT07094087 | Complex Cardiovascular Surgery With Cardiopulmonary Bypa |
| 2027-04-09 | Ph3 | Shanghai Henlius Biotech | NCT06847334 | Non-Squamous Non-Small Cell Lung Cancer |
| 2027-04-12 | Ph3 | Novartis Pharmaceuticals | NCT05624749 | Systemic Lupus Erythematosus |
| 2027-04-14 | Ph3 | Takeda | NCT06579755 | Dengue Fever |
| 2027-04-16 | Ph3 | AstraZeneca | NCT06307652 | Heart Failure and Impaired Kidney Function |
| 2027-04-16 | Ph3 | Staidson (Beijing) Biopharmaceuticals Co., L | NCT07168161 | ANCA Associated Vasculitis (AAV) |
| 2027-04-18 | Ph3 | Zydus Therapeutics Inc. | NCT06427395 | Primary Biliary Cholangitis |
| 2027-04-21 | Ph3 | BioNTech SE | NCT07798648 | COVID-19 Vaccines |
| 2027-04-25 | Ph3 | Almirall, S.A. | NCT06526182 | Dermatitis, Atopic; Eczema |
| 2027-04-27 | Ph3 | Amgen | NCT06987695 | Obesity Disease |
| 2027-04-28 | Ph3 | Boehringer Ingelheim | NCT06238622 | Idiopathic Pulmonary Fibrosis; Progressive Pulmonary Fib |
| 2027-04-28 | Ph3 | CSPC Ouyi Pharmaceutical Co., Ltd. | NCT06943950 | Moderate to Severe Plaque Psoriasis |
| 2027-04-30 | Ph3 | Innovent Biologics Technology Limited (Shang | NCT07414394 | Gout |
| 2027-04-30 | Ph2/Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06456528 | Cancer Treatment-Induced Thrombocytopenia |
| 2027-04-30 | Ph3 | Acerta Pharma BV | NCT03836261 | Chronic Lymphocytic Leukemia |
| 2027-04-30 | Ph3 | Bio-Thera Solutions | NCT07515079 | Diabetic Macular Edema (DME) |
| 2027-04-30 | Ph3 | BrightGene Bio-Medical Technology Co., Ltd. | NCT07064486 | Type 2 Diabetes (T2DM) |
| 2027-05-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT07300111 | Anaemia |
| 2027-05-01 | Ph2/Ph3 | Skyhawk Therapeutics, Inc. | NCT06873334 | Huntington Disease; Huntingtons Disease |
| 2027-05-01 | Ph3 | Alkermes, Inc. | NCT07502443 | Narcolepsy Type 2 |
| 2027-05-01 | Ph3 | Minoryx Therapeutics, S.L. | NCT05819866 | Cerebral Adrenoleukodystrophy (cALD) |
| 2027-05-01 | Ph3 | Eli Lilly and Company | NCT07613307 | Diabetes Mellitus, Type 2; Diabetes Melletus; Glucose Me |
| 2027-05-01 | Ph3 | Alkermes, Inc. | NCT07455383 | Narcolepsy Type 1 |
| 2027-05-01 | Ph3 | Gameto, Inc. | NCT06858111 | In Vitro Maturation of Oocytes |
| 2027-05-01 | Ph3 | Genetix Biotherapeutics Inc. | NCT04293185 | Sickle Cell Disease |
| 2027-05-01 | Ph3 | Verrica Pharmaceuticals Inc. | NCT07637734 | Common Warts; Common Warts (Verruca Vulgaris); Human Pap |
| 2027-05-01 | Ph3 | Priothera SAS | NCT05429632 | Adult Acute Myeloid Leukemia |
| 2027-05-01 | Ph3 | Beijing Kanghong Biological Medicine Co., Lt | NCT07720648 | Thyroid Eye Disease |
| 2027-05-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06884891 | Atopic Dermatitis |
| 2027-05-01 | Ph3 | Okyo Pharma Ltd | NCT07838506 | Neuropathic Corneal Pain |
| 2027-05-01 | Ph3 | Barbara Maglione | NCT07684833 | Chronic Venous Disease; Vein Disease; Venous Insufficien |
| 2027-05-01 | Ph3 | Mylan Pharmaceuticals Inc | NCT06672016 | Female Contraception |
| 2027-05-01 | Ph3 | IntraBio Inc | NCT07221292 | CACNA1A; Spinocerebellar Ataxia Type 6; Episodic Ataxia |
| 2027-05-01 | Ph3 | Crinetics Pharmaceuticals Inc. | NCT07144163 | Congenital Adrenal Hyperplasia; Classic Congenital Adren |
| 2027-05-01 | Ph3 | Aerogen Pharma Limited | NCT06776783 | Respiratory Distress Syndrome; Pre-term Infants |
| 2027-05-01 | Ph3 | Xenon Pharmaceuticals Inc. | NCT07076407 | Major Depressive Disorder |
| 2027-05-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06898060 | Postmenopausal Women With Osteoporosis |
| 2027-05-01 | Ph3 | Akeso | NCT06928389 | Non-Small Cell Lung Cancer |
| 2027-05-01 | Ph3 | Sichuan Baili Pharmaceutical Co., Ltd. | NCT06957886 | HER2-low Breast Cancer |
| 2027-05-01 | Ph3 | GRIN Therapeutics, Inc. | NCT07224581 | GRIN-related Neurodevelopmental Disorder |
| 2027-05-04 | Ph3 | Amgen | NCT05972551 | Osteogenesis Imperfecta |
| 2027-05-05 | Ph3 | Merck Sharp & Dohme LLC | NCT04380636 | Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
| 2027-05-06 | Ph3 | UCB Biopharma SRL | NCT05063162 | Myelin Oligodendrocyte Glycoprotein Antibody-associated |
| 2027-05-10 | Ph3 | Merck Sharp & Dohme LLC | NCT06074588 | Non-small Cell Lung Cancer (NSCLC) |
| 2027-05-10 | Ph3 | Novartis Pharmaceuticals | NCT05030428 | Atherosclerotic Cardiovascular Disease |
| 2027-05-12 | Ph3 | Novo Nordisk A/S | NCT07220759 | Overweight; Obesity; Type 2 Diabetes |
| 2027-05-14 | Ph3 | Akeso | NCT06953999 | Pancreatic Cancer |
| 2027-05-14 | Ph3 | GlaxoSmithKline | NCT06666491 | Malaria, Vivax |
| 2027-05-16 | Ph3 | Pfizer | NCT07819097 | Adult; Healthy Participants |
| 2027-05-17 | Ph3 | Novartis Pharmaceuticals | NCT06799000 | Hidradenitis Suppurativa |
| 2027-05-18 | Ph3 | Takeda | NCT06671496 | Psoriatic Arthritis |
| 2027-05-27 | Ph3 | Taiho Oncology, Inc. | NCT05973773 | Advanced or Metastatic NSCLS With Exon 20 Insertion Muta |
| 2027-05-27 | Ph3 | Merck Sharp & Dohme LLC | NCT05173987 | Endometrial Neoplasms |
| 2027-05-28 | Ph3 | AstraZeneca | NCT07619118 | Hypercholesterolaemia |
| 2027-05-28 | Ph3 | Otsuka Pharmaceutical Development & Commerci | NCT07209761 | Pulmonary Tuberculosis |
| 2027-05-30 | Ph2/Ph3 | Shanghai Xinzhi BioMed Co., Ltd. | NCT06111638 | Hemophilia A |
| 2027-05-30 | Ph3 | Takeda | NCT07752108 | Palmoplantar Psoriasis |
| 2027-05-31 | Ph3 | Suzhou Immunofoco Biotechnology Co., Ltd | NCT07103668 | Gastric Adenocarcinoma |
| 2027-05-31 | Ph3 | Sarepta Therapeutics, Inc. | NCT05881408 | Duchenne Muscular Dystrophy |
| 2027-05-31 | Ph3 | Tasly Pharmaceutical Group Co., Ltd | NCT06773117 | Cough |
| 2027-05-31 | Ph3 | Evopoint Biosciences Inc. | NCT07823049 | Pancreatic Cancer |
| 2027-05-31 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT06628908 | Diabetic Peripheral Neuropathic Pain |
| 2027-05-31 | Ph3 | Shanghai JMT-Bio Inc. | NCT06221072 | Imaging Examination Shows at Least One Site With Bone Me |
| 2027-05-31 | Ph3 | Taisho Pharmaceutical Co., Ltd. | NCT07548853 | Hyperphosphatemia Patients on Peritoneal Dialysis |
| 2027-05-31 | Ph3 | Annexon, Inc. | NCT07020819 | Guillain-Barre Syndrome |
| 2027-06-01 | Ph3 | Genexine, Inc. | NCT06466785 | Anemia of Chronic Kidney Disease |
| 2027-06-01 | Ph3 | Shanghai Henlius Biotech | NCT06532006 | Gastroesophageal-junction Cancer; Monoclonal Antibody; G |
| 2027-06-01 | Ph3 | RenovoRx | NCT03257033 | Locally Advanced Pancreatic Cancer |
| 2027-06-01 | Ph3 | Vedanta Biosciences, Inc. | NCT06237452 | Clostridium Difficile; Clostridium Difficile Infections; |
| 2027-06-01 | Ph3 | Savara Inc. | NCT06431776 | Autoimmune Pulmonary Alveolar Proteinosis |
| 2027-06-01 | Ph2/Ph3 | Beijing Suncadia Pharmaceuticals Co., Ltd | NCT06732648 | Severe Cerebral Edema Following Large Hemispheric Infarc |
| 2027-06-01 | Ph3 | Genfleet Therapeutics (Shanghai) Inc. | NCT07262567 | Metastatic Pancreatic Cancer |
| 2027-06-01 | Ph3 | Renibus Therapeutics, Inc. | NCT07355062 | CKD; Metabolic Acidosis |
| 2027-06-01 | Ph3 | Lepu Biopharma Co., Ltd. | NCT07138846 | Advanced Pancreatic Cancer |
| 2027-06-01 | Ph3 | Pharvaris Netherlands B.V. | NCT07266805 | Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE- |
| 2027-06-01 | Ph3 | Alfasigma S.p.A. | NCT07554495 | Polyarticular Course Juvenile Idiopathic Arthritis |
| 2027-06-01 | Ph3 | Verrica Pharmaceuticals Inc. | NCT07246590 | Common Warts; Common Warts (Verruca Vulgaris); Human Pap |
| 2027-06-01 | Ph3 | Genmab | NCT05578976 | Diffuse Large B-Cell Lymphoma |
| 2027-06-01 | Ph3 | Sichuan Baili Pharmaceutical Co., Ltd. | NCT06994195 | Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primar |
| 2027-06-01 | Ph3 | MindRank AI Ltd | NCT07274137 | Overweight or Obesity |
| 2027-06-01 | Ph3 | Brainfarma Industria Química e Farmacêutica | NCT07712913 | Diabetic Neuropathy; Neuropathic Pain; Neuralgia, Posthe |
| 2027-06-01 | Ph3 | ITM Solucin GmbH | NCT04919226 | Neuroendocrine Tumors |
| 2027-06-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06732323 | Triple-Negative Breast Cancer (TNBC) |
| 2027-06-01 | Ph3 | Gilead Sciences | NCT05633654 | Triple Negative Breast Cancer |
| 2027-06-01 | Ph3 | Sinotau Pharmaceutical Group | NCT07439133 | Coronary Artery Disease(CAD) |
| 2027-06-01 | Ph3 | Shanghai HEP Pharmaceutical Co., Ltd. | NCT07309380 | Hepatitis D, Chronic |
| 2027-06-01 | Ph3 | EBI Anti Sepsis BV | NCT07357675 | Coronary Artery Disease (CAD); Coronary Artery Bypass Gr |
| 2027-06-01 | Ph3 | Immutep S.A.S. | NCT06726265 | Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) |
| 2027-06-01 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT03980054 | Breast Cancer |
| 2027-06-01 | Ph3 | 4D Molecular Therapeutics | NCT06864988 | Macular Neovascularization Secondary to Age-Related Macu |
| 2027-06-01 | Ph3 | Veradermics, Inc. | NCT07146022 | Androgenetic Alopecia (AGA); Androgenetic Alopecia; AGA; |
| 2027-06-01 | Ph3 | Chongqing Claruvis Pharmaceutical Co., Ltd. | NCT07478822 | Upper Limb Spasticity |
| 2027-06-01 | Ph3 | Alkermes, Inc. | NCT07540897 | Narcolepsy Type 1 |
| 2027-06-01 | Ph3 | Sichuan Baili Pharmaceutical Co., Ltd. | NCT06857175 | Urothelial Carcinoma |
| 2027-06-01 | Ph3 | Lantheus Biosciences Ltd. | NCT05641688 | Alzheimer Disease |
| 2027-06-01 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT06406205 | Lupus Nephritis |
| 2027-06-02 | Ph3 | Sanofi | NCT05263206 | Pruritus |
| 2027-06-02 | Ph3 | Novartis Pharmaceuticals | NCT06401356 | Hematologic Malignancy; Solid Tumor; Advanced Malignanci |
| 2027-06-06 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT05329649 | Sickle Cell Disease; Hydroxyurea Failure; Hydroxyurea In |
| 2027-06-07 | Ph3 | Sanofi | NCT07348692 | Pneumococcal Immunization; Healthy Volunteers |
| 2027-06-07 | Ph3 | Jemincare | NCT07402213 | Chronic Spontaneous Urticaria |
| 2027-06-07 | Ph3 | Cybin IRL Limited | NCT06793397 | Major Depressive Disorder (MDD); Depression in Adults; D |
| 2027-06-08 | Ph3 | Takeda | NCT06227910 | Crohn's Disease |
| 2027-06-09 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT05477563 | Beta-Thalassemia; Thalassemia; Hematologic Diseases; Gen |
| 2027-06-11 | Ph3 | Haisco Pharmaceutical Group Co., Ltd. | NCT07658339 | COPD (Chronic Obstructive Pulmonary Disease) |
| 2027-06-15 | Ph3 | Boehringer Ingelheim | NCT06872892 | Bronchiectasis |
| 2027-06-21 | Ph3 | Intra-Cellular Therapies, Inc. | NCT06706674 | Irritability Associated With Autism Spectrum Disorder |
| 2027-06-21 | Ph3 | Intra-Cellular Therapies, Inc. | NCT06690398 | Irritability Associated With Autism Spectrum Disorder |
| 2027-06-28 | Ph3 | Bristol-Myers Squibb | NCT07140913 | Mania; Bipolar Disorder |
| 2027-06-29 | Ph3 | Psicofarma, S.A. De C.V. | NCT07477990 | General Anxiety Disorder |
| 2027-06-30 | Ph3 | Gan & Lee Pharmaceuticals. | NCT07150975 | Obesity/Overweight in Adult |
| 2027-06-30 | Ph3 | Innovent Biologics (Suzhou) Co. Ltd. | NCT07066098 | Pancreatic Cancer |
| 2027-06-30 | Ph3 | Belite Bio, Inc | NCT05949593 | Geographic Atrophy |
| 2027-06-30 | Ph2/Ph3 | Janssen Research & Development, LLC | NCT05265273 | Myasthenia Gravis |
| 2027-06-30 | Ph2/Ph3 | Gipfel Life Sciences GmbH | NCT07321860 | ALS (Amyotrophic Lateral Sclerosis) |
| 2027-06-30 | Ph3 | StemCyte, Inc. | NCT07184385 | Long COVID; Post-COVID-19 Condition; Post-COVID Syndrome |
| 2027-06-30 | Ph3 | Norroy Bioscience Co., LTD | NCT07615101 | Prostate Cancer (Diagnosis) |
| 2027-06-30 | Ph3 | Changchun GeneScience Pharmaceutical Co., Lt | NCT07150663 | Non-small Cell Lung Cancer |
| 2027-06-30 | Ph3 | Ascentage Pharma Group Inc. | NCT06423911 | Chronic Myeloid Leukemia; CML; CML, Chronic Phase |
| 2027-06-30 | Ph3 | Cidara Therapeutics Inc., a subsidiary of Me | NCT07159763 | Influenza |
| 2027-06-30 | Ph3 | MicuRx | NCT05369052 | Diabetic Foot Infection |
| 2027-06-30 | Ph2/Ph3 | Hoffmann-La Roche | NCT03178552 | Non-Small Cell Lung Cancer |
| 2027-06-30 | Ph2/Ph3 | Lunan Better Pharmaceutical Co., LTD. | NCT06765993 | Meniere´s Disease |
| 2027-06-30 | Ph3 | Changchun GeneScience Pharmaceutical Co., Lt | NCT06772428 | Head and Neck Squamous Cell Carcinoma; Underwent Surgery |
| 2027-06-30 | Ph3 | Shanghai Hutchison Pharmaceuticals Limited | NCT07241520 | Acute Ischemic Stroke |
| 2027-06-30 | Ph3 | Jiangsu HengRui Medicine Co., Ltd. | NCT06123494 | HER2-positive Advanced Gastric Cancer or Gastroesophagea |
| 2027-06-30 | Ph3 | CUTISS AG | NCT06745557 | Burns |
| 2027-06-30 | Ph3 | Changchun GeneScience Pharmaceutical Co., Lt | NCT07356037 | Cachexia; Hepatocellular Carcinoma |
| 2027-06-30 | Ph3 | AstraZeneca | NCT04550260 | Esophageal Squamous Cell Carcinoma |
| 2027-06-30 | Ph3 | CSL Behring | NCT06617897 | Acquired Fibrinogen Deficiency |
| 2027-07-01 | Ph3 | Sinovac Life Sciences Co., Ltd. | NCT07593924 | Pneumococcal Infectious Diseases |
| 2027-07-01 | Ph3 | Paradigm Biopharmaceuticals Ltd. | NCT06917404 | Osteoarthritis, Knee |
| 2027-07-01 | Ph3 | NervGen Pharma | NCT07799532 | Chronic Spinal Cord Injury |
| 2027-07-01 | Ph3 | Biotheus Inc. | NCT06419621 | Triple Negative Breast Cancer(TNBC) |
| 2027-07-01 | Ph3 | Neurocrine Biosciences | NCT06963021 | Major Depressive Disorder |
| 2027-07-01 | Ph3 | argenx | NCT06684847 | Primary Sjogrens Disease |
| 2027-07-01 | Ph3 | Eli Lilly and Company | NCT07232719 | Obesity; Overweight |
| 2027-07-01 | Ph3 | AbbVie | NCT04333576 | Endometriosis |
| 2027-07-01 | Ph3 | Viking Therapeutics, Inc. | NCT07104500 | Weight Loss |
| 2027-07-01 | Ph3 | Mesoblast, Ltd. | NCT06325566 | Degenerative Disc Disease |
| 2027-07-01 | Ph2/Ph3 | PT. Prodia Stem Cell Indonesia | NCT05909488 | Retinitis Pigmentosa |
| 2027-07-01 | Ph2/Ph3 | Rapa Therapeutics LLC | NCT04220190 | Amyotrophic Lateral Sclerosis |
| 2027-07-01 | Ph3 | GL Pharm Tech Corporation | NCT07859202 | Erectile Dysfunctions |
| 2027-07-01 | Ph3 | Trust Bio-sonics, Inc. | NCT07740421 | Cardiac Diseases |
| 2027-07-01 | Ph3 | Shijiazhuang Yiling Pharmaceutical Co. Ltd | NCT05876832 | Acute Myeloid Leukemia With FLT3/ITD Mutation |
| 2027-07-01 | Ph3 | SANGMYUNG innovation | NCT07708142 | Retinal Vein Occlusion With Macular Edema |
| 2027-07-01 | Ph3 | Infectopharm Arzneimittel GmbH | NCT06380452 | Scabies |
| 2027-07-01 | Ph3 | Shanghai Henlius Biotech | NCT06895512 | Newly Diagnosed Multiple Myeloma |
| 2027-07-01 | Ph3 | Biocells (Beijing) Biotech Co.,Ltd | NCT07520565 | AIS |
| 2027-07-01 | Ph3 | Amicus Therapeutics | NCT04808505 | Glycogen Storage Disease Type II Infantile Onset |
| 2027-07-01 | Ph3 | Intellia Therapeutics | NCT06672237 | Neuromuscular Disease; Neuromuscular Diseases (NMD); Neu |
| 2027-07-01 | Ph3 | Shanghai Yizhong Pharmaceutical Co., Ltd. | NCT06752811 | Pancreatic Cancer Metastatic |
| 2027-07-01 | Ph2/Ph3 | Sunshine Lake Pharma Co., Ltd. | NCT04984512 | Depressive Disorder, Major |
| 2027-07-01 | Ph3 | Viatris Innovation GmbH | NCT04957719 | Acute Myocardial Infarction |
| 2027-07-01 | Ph3 | Sinocelltech Ltd. | NCT07362459 | Non-Small Cell Lung Carcinoma (NSCLC) |
| 2027-07-06 | Ph3 | H. Lundbeck A/S | NCT05897320 | Episodic Migraine |
| 2027-07-09 | Ph3 | GlaxoSmithKline | NCT07851246 | Influenza, Human |
| 2027-07-09 | Ph3 | Sanofi | NCT06290141 | Chronic Inflammatory Demyelinating Polyneuropathy |
| 2027-07-09 | Ph3 | Chendu DIAO Pharmaceutical Group CO., LTD. | NCT07629544 | Overweight and Obesity |
| 2027-07-10 | Ph3 | Akeso | NCT06767540 | Atopic Dermatitis |
| 2027-07-15 | Ph3 | Jiangsu Simcere Pharmaceutical Co., Ltd. | NCT07881705 | Myelosuppression |
| 2027-07-15 | Ph3 | Sanofi | NCT07325292 | Multiple Sclerosis |
| 2027-07-15 | Ph3 | AstraZeneca | NCT05057494 | Chronic Lymphocytic Leukemia or Small Lymphocytic Lympho |
| 2027-07-18 | Ph3 | Amgen | NCT06321601 | Vasculitis |
| 2027-07-22 | Ph3 | Merck Sharp & Dohme LLC | NCT07044297 | Human Immunodeficiency Virus (HIV); HIV Pre-Exposure Pro |
| 2027-07-23 | Ph3 | Sanofi | NCT06975865 | Sickle Cell Disease |
| 2027-07-27 | Ph3 | AstraZeneca | NCT07007793 | Primary Hyperaldosteronism |
| 2027-07-28 | Ph3 | InventisBio Co., Ltd | NCT07130604 | Plaque Psoriasis |
| 2027-07-30 | Ph3 | Genmab | NCT06635824 | PD-L1-positive, Locally Advanced (Unresectable Stage III |
| 2027-07-30 | Ph3 | Shanghai Bovax Biotechnology Co., Ltd. | NCT06465914 | Genital Wart; Penile Cancer; Anal Cancer; PIN-1; PIN2; P |
| 2027-07-30 | Ph3 | AstraZeneca | NCT07619131 | Hypercholesterolaemia |
| 2027-07-30 | Ph3 | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | NCT06574503 | Influenza |
| 2027-07-31 | Ph3 | Maia Biotechnology | NCT06908304 | Carcinoma, Non-Small -Cell Lung |
| 2027-07-31 | Ph3 | Shionogi | NCT07746544 | COVID-19 |
| 2027-08-01 | Ph2/Ph3 | Bostal Drug Delivery Co., Ltd | NCT07722728 | Schizophrenia |
| 2027-08-01 | Ph2/Ph3 | Biohaven Therapeutics Ltd. | NCT06976268 | Parkinson Disease |
| 2027-08-01 | Ph2/Ph3 | Integrant Pty Ltd | NCT06907121 | Arthritis Ankle; Arthritis Knee |
| 2027-08-01 | Ph3 | AbbVie | NCT03844048 | Chronic Lymphocytic Leukemia; Acute Myeloid Leukemia; Mu |
| 2027-08-01 | Ph3 | AVEO Pharmaceuticals, Inc. | NCT06064877 | Metastatic Head-and-neck Squamous-cell Carcinoma; Recurr |
| 2027-08-01 | Ph2/Ph3 | Bostal Drug Delivery Co., Ltd | NCT07742280 | Schizophrenia |
| 2027-08-01 | Ph3 | Eli Lilly and Company | NCT06972472 | Obesity; Overweight; Type 2 Diabetes |
| 2027-08-01 | Ph2/Ph3 | Otsuka Pharmaceutical Co., Ltd. | NCT07086313 | Attention-Deficit Hyperactivity Disorder(ADHD) |
| 2027-08-01 | Ph3 | Eli Lilly and Company | NCT06993792 | Obesity; Overweight; Type 2 Diabetes |
| 2027-08-01 | Ph3 | Nanjing IASO Biotechnology Co., Ltd. | NCT06464991 | Multiple Myeloma |
| 2027-08-01 | Ph3 | Opus Genetics, Inc | NCT07140783 | Vision Loss Night; Vision Disorders |
| 2027-08-01 | Ph3 | Caliway Biopharmaceuticals Co., Ltd. | NCT07526974 | Subcutaneous Fat |
| 2027-08-01 | Ph3 | Trevi Therapeutics | NCT07868419 | Idiopathic Pulmonary Fibrosis |
| 2027-08-01 | Ph3 | Sagimet Biosciences Inc. | NCT07863193 | Acne Vulgaris |
| 2027-08-01 | Ph3 | HK inno.N Corporation | NCT07308184 | Diabetes (DM); Diabetes Mellitus Type 2 |
| 2027-08-01 | Ph3 | Ascendis Pharma A/S | NCT07706764 | Hypoparathyroidism |
| 2027-08-01 | Ph3 | Shandong Suncadia Medicine Co., Ltd. | NCT07024173 | Locally Advanced Breast Cancer; Metastatic Breast Cancer |
| 2027-08-01 | Ph3 | Ultragenyx Pharmaceutical Inc | NCT05933200 | Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) |
| 2027-08-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Nanji | NCT07483684 | HER2 IHC3+ Advanced Colorectal Cancer |
| 2027-08-01 | Ph3 | Ultragenyx Pharmaceutical Inc | NCT04360265 | Mucopolysaccharidosis IIIA; MPS IIIA; Sanfilippo Syndrom |
| 2027-08-01 | Ph3 | Ascentage Pharma Group Inc. | NCT06319456 | CLL/SLL |
| 2027-08-01 | Ph3 | Eli Lilly and Company | NCT06972459 | Obesity; Overweight |
| 2027-08-01 | Ph3 | Onconic Therapeutics Inc. | NCT06439563 | Peptic Ulcer |
| 2027-08-02 | Ph3 | AstraZeneca | NCT05120349 | Non-Small Cell Lung Cancer |
| 2027-08-04 | Ph3 | Pfizer | NCT05317416 | Multiple Myeloma |
| 2027-08-05 | Ph3 | Janssen Research & Development, LLC | NCT05912517 | Hemolytic Disease of the Fetus and Newborn |
| 2027-08-09 | Ph3 | Celgene | NCT06356129 | Large B-cell Lymphoma |
| 2027-08-10 | Ph3 | Novartis Pharmaceuticals | NCT05852938 | IgA Nephropathy; Immunoglobulin A Nephropathy |
| 2027-08-17 | Ph3 | Bristol-Myers Squibb | NCT06646276 | Extensive-Stage Small Cell Lung Cancer |
| 2027-08-17 | Ph3 | Alexion Pharmaceuticals, Inc. | NCT07596784 | Generalized Myasthenia Gravis; gMG |
| 2027-08-20 | Ph3 | Amgen | NCT07225686 | Obesity; Obstructive Sleep Apnea |
| 2027-08-20 | Ph3 | Arrowhead Pharmaceuticals | NCT07037771 | Homozygous Familial Hypercholesterolemia |
| 2027-08-23 | Ph3 | GlaxoSmithKline | NCT05371080 | Herpes Zoster |
| 2027-08-25 | Ph3 | Sanofi | NCT06975878 | Pneumococcal Immunization; Healthy Volunteers |
| 2027-08-27 | Ph3 | Novo Nordisk A/S | NCT06612268 | Sickle Cell Disease |
| 2027-08-27 | Ph3 | GlaxoSmithKline | NCT07650084 | Refractory Chronic Cough |
| 2027-08-28 | Ph3 | Hangzhou Zhongmei Huadong Pharmaceutical Co. | NCT07394114 | Type 2 Diabetes |
| 2027-08-30 | Ph3 | Insud Pharma | NCT04024163 | Chagas Disease |
| 2027-08-30 | Ph3 | Jiangsu vcare pharmaceutical technology co., | NCT07172360 | Active Ankylosing Spondylitis |
| 2027-08-30 | Ph3 | Hangzhou Zhongmei Huadong Pharmaceutical Co. | NCT07417306 | Type 2 Diabetes |
| 2027-08-30 | Ph3 | SOFIE | NCT07217704 | Esophageal Cancer; Gastric Cancer (GC); Gastroesophageal |
| 2027-08-31 | Ph2/Ph3 | Mirum Pharmaceuticals, Inc. | NCT07454837 | Chronic Hepatitis D |
| 2027-08-31 | Ph3 | Il-Yang Pharm. Co., Ltd. | NCT07870759 | Benign Prostatic Hyperplasia |
| 2027-08-31 | Ph2/Ph3 | Compass Therapeutics | NCT05506943 | Biliary Tract Cancer; Cholangiocarcinoma; Gall Bladder C |
| 2027-08-31 | Ph3 | Telix Pharmaceuticals (Innovations) Pty Limi | NCT07197580 | ccRCC; Renal Cell Carcinoma (Kidney Cancer); Renal Cell |
| 2027-08-31 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT05487391 | Carcinoma, Non-Small-Cell Lung |
| 2027-08-31 | Ph3 | OncoC4, Inc. | NCT05671510 | Non Small Cell Lung Cancer |
| 2027-08-31 | Ph3 | Minghui Pharmaceutical (Hangzhou) Ltd | NCT07257185 | Thyroid Eye Disease (TED) |
| 2027-09-01 | Ph3 | Lee's Pharmaceutical Limited | NCT06459687 | Cervical Cancer |
| 2027-09-01 | Ph3 | Cytokinetics | NCT06736574 | Heart Failure; Heart Failure With Reduced Ejection Fract |
| 2027-09-01 | Ph3 | Pharmazz, Inc. | NCT05691244 | Acute Ischemic Stroke; Cerebral Stroke |
| 2027-09-01 | Ph3 | Eli Lilly and Company | NCT07035093 | Obesity; Overweight; Chronic Low Back Pain (CLBP) |
| 2027-09-01 | Ph3 | Applied Biologics, LLC | NCT07852338 | Diabetic Foot Ulcer; Amniotic Membrane Placental Allogra |
| 2027-09-01 | Ph3 | Alkermes, Inc. | NCT04987229 | Bipolar I Disorder; Schizophrenia |
| 2027-09-01 | Ph3 | Genmab | NCT07604766 | Platinum-resistant Ovarian Cancer |
| 2027-09-01 | Ph2/Ph3 | Kardigan, Inc. | NCT07210723 | Symptomatic Genetic Dilated Cardiomyopathy |
| 2027-09-01 | Ph3 | Castle Creek Biosciences, LLC. | NCT06892639 | Dystrophic Epidermolysis Bullosa |
| 2027-09-01 | Ph3 | Ultragenyx Pharmaceutical Inc | NCT05345171 | OTC Deficiency |
| 2027-09-01 | Ph3 | AstraZeneca | NCT05629585 | Breast Cancer |
| 2027-09-01 | Ph2/Ph3 | AbbVie | NCT06345339 | Hypothyroidism |
| 2027-09-01 | Ph3 | Definium Therapeutics US, Inc. | NCT07592689 | Major Depressive Disorder |
| 2027-09-01 | Ph3 | Dr. Falk Pharma GmbH | NCT06886360 | Primary Sclerosing Cholangitis |
| 2027-09-01 | Ph2/Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT05976568 | Hepatocellular Carcinoma |
| 2027-09-01 | Ph3 | Novo Nordisk A/S | NCT05669755 | Cardiovascular Disease |
| 2027-09-01 | Ph3 | argenx | NCT06920004 | Chronic Inflammatory Demyelinating Polyneuropathy; CIDP; |
| 2027-09-01 | Ph3 | Alvogen Korea | NCT07678827 | Attention Deficit Hyperactivity Disorder; Attention-Defi |
| 2027-09-01 | Ph2/Ph3 | argenx | NCT06392386 | Generalized Myasthenia Gravis |
| 2027-09-01 | Ph3 | Chia Tai Tianqing Pharmaceutical Group Nanji | NCT07043725 | HER2-positive Breast Cancer |
| 2027-09-01 | Ph3 | Keymed Biosciences Co.Ltd | NCT07181239 | Multiple Myeloma (MM) |
| 2027-09-01 | Ph3 | Otsuka Pharmaceutical Co., Ltd. | NCT05325645 | Acute Schizophrenia |
| 2027-09-01 | Ph3 | Joincare Pharmaceutical Group Industry Co., | NCT07330310 | Chronic Obstructive Pulmonary Disease (COPD) |
| 2027-09-01 | Ph3 | Guangdong Hengrui Pharmaceutical Co., Ltd | NCT06653322 | Asthma With Eosinophilic Phenotype |
| 2027-09-07 | Ph3 | Karuna Therapeutics, Inc., a Bristol Myers S | NCT05980949 | Psychosis Associated With Alzheimer's Disease |
| 2027-09-10 | Ph3 | Sanofi | NCT06824181 | Pneumococcal Immunization |
| 2027-09-12 | Ph3 | Celgene | NCT06764485 | Metastatic Castration-resistant Prostate Cancer |
| 2027-09-19 | Ph3 | Paradigm Therapeutics | NCT07482813 | Epidermolysis Bullosa (EB) |
| 2027-09-20 | Ph3 | Shanghai Hengrui Pharmaceutical Co., Ltd. | NCT06649292 | Second-line Advanced or Metastatic Gastric or Gastroesop |
| 2027-09-21 | Ph3 | Novartis Pharmaceuticals | NCT05126277 | Lupus Nephritis |
| 2027-09-21 | Ph3 | Pfizer | NCT07311850 | Obesity and Overweight |
| 2027-09-22 | Ph3 | Shanghai Kechow Pharma, Inc. | NCT06008106 | Melanoma |
| 2027-09-24 | Ph3 | Biogen | NCT05067790 | Spinal Muscular Atrophy |
| 2027-09-24 | Ph2/Ph3 | Merck Sharp & Dohme LLC | NCT05139017 | DLBCL; Diffuse Large B-Cell Lymphoma |
| 2027-09-24 | Ph3 | The United Bio-Technology (Hengqin) Co., Ltd | NCT07659574 | Type 2 Diabetes |
| 2027-09-27 | Ph2/Ph3 | Cellcolabs Clinical SPV Limited | NCT07542808 | Knee Arthritis Osteoarthritis |
| 2027-09-28 | Ph3 | Merck Sharp & Dohme LLC | NCT06456346 | Essential Thrombocythemia |
| 2027-09-28 | Ph3 | Pfizer | NCT07013474 | COVID-19 Infection |
| 2027-09-28 | Ph3 | Incyte Corporation | NCT06585774 | Chronic Graft-versus-host-disease |
| 2027-09-28 | Ph3 | Janssen Research & Development, LLC | NCT07217587 | Myasthenia Gravis |
| 2027-09-30 | Ph3 | AstraZeneca | NCT06120491 | Metastatic Castration-Sensitive Prostate Cancer |
| 2027-09-30 | Ph3 | Vanda Pharmaceuticals | NCT06138613 | Motion Sickness |
| 2027-09-30 | Ph3 | Shanghai RAAS Blood Products Co., Ltd. | NCT07876674 | Hemophilia A; Hemophilia A and B; Hemophilia B |
| 2027-09-30 | Ph3 | CSPC Megalith Biopharmaceutical Co.,Ltd. | NCT07633873 | Non-Small Cell Lung Cancer |
| 2027-09-30 | Ph3 | Avecho Biotechnology | NCT05840822 | Insomnia |
| 2027-09-30 | Ph3 | Biomed Industries, Inc. | NCT06840496 | Rett Syndrome |
| 2027-09-30 | Ph3 | Ono Pharmaceutical Co., Ltd. | NCT06696716 | Pemphigus; Steroid-resistant Pemphigus |
| 2027-09-30 | Ph2/Ph3 | Shanghai Zhimeng Biopharma, Inc. | NCT07082192 | ALS (Amyotrophic Lateral Sclerosis) |
| 2027-09-30 | Ph3 | Bisirna Therapeutics (Suzhou) Co., Ltd. | NCT07816237 | Paroxysmal Nocturnal Hemoglobinuria, PNH |
| 2027-09-30 | Ph3 | Vertex Pharmaceuticals Incorporated | NCT06460506 | Cystic Fibrosis |
| 2027-09-30 | Ph3 | CSPC Mingfule Pharmaceutical (Guangzhou) Co. | NCT07201688 | Acute Ischemic Stroke |
| 2027-09-30 | Ph3 | Chong Kun Dang Pharmaceutical | NCT06916793 | Androgenetic Alopecia |
| 2027-10-01 | Ph3 | EyePoint Pharmaceuticals, Inc. | NCT07449923 | Diabetic Macular Edema; DME; Diabetic Macular Edema (DME |
| 2027-10-01 | Ph2/Ph3 | BeOne Medicines | NCT05707377 | Primary Membranous Nephropathy |
| 2027-10-01 | Ph3 | Eli Lilly and Company | NCT06439277 | Obesity; Weight Gain |
| 2027-10-01 | Ph3 | Eli Lilly and Company | NCT05556512 | Obesity; Overweight |
| 2027-10-01 | Ph3 | Chengdu Suncadia Medicine Co., Ltd. | NCT07014826 | Primary IgA Nephropathy |
| 2027-10-01 | Ph3 | Carnot Laboratories | NCT07628985 | Type 2 Diabetes Mellitus (T2DM) |
| 2027-10-01 | Ph3 | Fujian Mindong Rejuvenation Pharmaceutical C | NCT07711262 | Seasonal Allergic Rhinitis |
| 2027-10-01 | Ph3 | Bukwang Pharmaceutical | NCT07781293 | Major Depressive Disorder (MDD); Major Depressive Disord |
| 2027-10-01 | Ph3 | Kallyope Inc. | NCT07816367 | Migraine |
| 2027-10-01 | Ph2/Ph3 | Zhejiang Vimgreen Pharmaceuticals, Ltd. | NCT07725562 | Parkinson Disease (PD) |
| 2027-10-01 | Ph2/Ph3 | Acacia Pharma Ltd | NCT04851717 | Pediatric ALL |
| 2027-10-07 | Ph3 | argenx | NCT07091630 | Chronic Inflammatory Demyelinating Polyneuropathy; CIDP; |
| 2027-10-07 | Ph3 | Qilu Pharmaceutical Co., Ltd. | NCT07444086 | Primary Hypercholesterolemia or Mixed Hyperlipidemia |
| 2027-10-13 | Ph3 | AstraZeneca | NCT06307665 | Asthma |
| 2027-10-15 | Ph2/Ph3 | Transdermal Delivery Solutions Corp | NCT05159453 | Glucose, High Blood |
| 2027-10-15 | Ph3 | AstraZeneca | NCT07044336 | Endometrial Cancer; Malignant Solid Tumour |
| 2027-10-15 | Ph3 | Servier Affaires Médicales | NCT05907057 | Acute Myeloid Leukemia (AML) |
| 2027-10-16 | Ph3 | Immunocore Ltd | NCT06112314 | Advanced Melanoma |
| 2027-10-18 | Ph3 | Novartis Pharmaceuticals | NCT04747613 | Paroxysmal Nocturnal Hemoglobinuria |
| 2027-10-18 | Ph3 | Merck Sharp & Dohme LLC | NCT07071623 | Human Immunodeficiency Virus (HIV); HIV Pre-Exposure Pro |
| 2027-10-20 | Ph2/Ph3 | Suzhou Kintor Pharmaceutical Inc, | NCT06622824 | Androgenetic Alopecia (AGA) |
| 2027-10-20 | Ph3 | Throne Biotechnologies Inc. | NCT04011020 | Type 1 Diabetes |
| 2027-10-20 | Ph3 | Phathom Pharmaceuticals, Inc. | NCT07752407 | Symptomatic Non-erosive Gastroesophageal Reflux Disease |
| 2027-10-26 | Ph3 | UCB Biopharma SRL | NCT06435312 | Generalized Myasthenia Gravis |
| 2027-10-27 | Ph3 | Janssen Research & Development, LLC | NCT05923073 | Crohn's Disease |
| 2027-10-28 | Ph2/Ph3 | Prokrea BCN, S.L. | NCT07669584 | Infertility Due to Azoospermia |
| 2027-10-28 | Ph3 | Galderma R&D | NCT07762833 | Atopic Dermatitis |
| 2027-10-28 | Ph3 | Merck Sharp & Dohme LLC | NCT04624204 | Small Cell Lung Cancer |
| 2027-10-28 | Ph3 | Bayer | NCT06452277 | Advanced Non-small Cell Lung Cancer, HER2 Mutation |